Skip to content

VKTX - Viking Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchV

Viking Therapeutics Inc

VKTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

V

VKTXViking Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $43.15
52-wk low: $22.96
Prev close: $32.48
Mkt cap: $3.89B
Beta: 0.69
P/B: 9.6x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$1.0B

TS
Two Sigma
Q2 2026 13F
$153.6M
position
DS
D.E. Shaw
Q2 2026 13F

Earnings

Reported Jul 29, 2026

Earnings came in 9.1% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $3.9B

Valuation

P/B9.61

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: VKTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $3.89B
Beta: 0.69

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-88.8%

$62.6M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$37.1M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for VKTX

No recent Congress trade
No recent market-voice mention

Earnings per share

-$1.10+9.1%

-$1.21 expected

Next report

What the street expects next

EPS expected

-$1.10

-$1.45 to -$0.75

Revenue expected

$0.00

16 analysts

Last 30 days

2up1down

Analysts raising estimates

Estimate drift

+0.01

Change in 30 days

-88.8%

ROA-51.9%

Growth

Beta0.69